SYNGENE.NS Cash Flow
Syngene International Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 00:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹8.23 Bn | ₹10.42 Bn | ₹11.68 Bn | ₹9.15 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-6.56 Bn | ₹-4.96 Bn | ₹-7.45 Bn | ₹-8.60 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-3.42 Bn | ₹-5.51 Bn | ₹-1.42 Bn | ₹-2.15 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹0.03 Bn | ₹0.01 Bn | ₹0.00 Bn | ₹0.22 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹-1.72 Bn | ₹-0.04 Bn | ₹2.81 Bn | ₹-1.39 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹2.62 Bn | ₹0.90 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from SYNGENE.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).